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EXECUTIVE SUMMARY

Cirbo, Elizabeth Leigh. Hepatitis C Screening in Primary Care. Unpublished Doctor of
Nursing Practice capstone project, University of Northern Colorado, 2017.
Primary care clinics are often the first stop when a patient has a question
regarding health, needs screening for health conditions, and/or needs to complete
maintenance healthcare items such as mammograms or colonoscopies. As such, primary
care providers are in prime position to screen for possible diseases that could poorly
affect health for their patients. These screenings are usually directed by guidelines and
policies published through the National Guideline Clearinghouse (NGC) and the Agency
for Healthcare Research and Quality (AHRQ; 2013). One such guideline is entitled
Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force
(2013) recommendation statement. This guideline recommends that all persons born
between 1945 to 1965 be screened once in a lifetime for the Hepatitis C virus (HCV).
The recommendation is because chronic HCV infection can lead to decreased quality of
life and high cost of care for the individual and the healthcare system if left untreated.
Untreated HCV can lead to liver cirrhosis and hepatocellular carcinoma. A person who
screens positive for infection with HCV can be appropriately treated and, in most cases,
have complete disease eradication.
From the researcher’s clinical experiences, the screening processes in many
primary care clinics in northern Colorado were lacking in numbers of patients screened
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and provider knowledge of when to screen their patients. The researcher developed a
capstone project to implement at a primary care clinic through the use of three objectives:
1.

Increase screening rates for HCV at a primary care clinic

2.

Identify a barrier preventing providers from screening patients for HCV

3.

Overcome the barrier preventing screening for HCV

Objective 1 was met through the use of an electronic medical record (EMR)
review of patients who completed well-visits at the clinic before and after an educational
seminar with the providers and staff at the clinic. Objectives 2 and 3 were met through
an educational seminar to identify and overcome barriers through the use of surveys and
handouts, respectively. The educational seminar allowed the researcher to offer
screening coding tips to help with insurance coverage (as this was the barrier identified
that prevented screening) and also to refresh providers and staff on the importance of
HCV screening per the guideline for the birth cohort born from 1945 to 1965. The EMR
reviews of well-visits showed a 30% increase in screening rates for HCV at this clinic-the pre-seminar rate was 37.8% and the post-seminar rate was 68.89%. This shows the
capstone project was a success to increase screening rates, identify a barrier preventing
screening, and overcome this barrier. Success of this capstone will have effects into the
future as hopefully, the providers and staff continue to increase HCV screening rates for
patients at the clinic. The continued increase in screening rates could insure proper
offering of treatment to patients identified as having positive HCV status to increase
quality of life by preventing worse negative sequalae associated with chronic HCV
infection.

iv

DEDICATIONS AND ACKNOWLEDGEMENTS

I would like to dedicate this capstone project to my husband, Lucas, and son,
Elijah. Through this process, they offered me endless support, love, and encouragement.
Without your cheering me on, laughter, and devotion through the last four years, I’m not
sure I would have made it!
It is also important to acknowledge and profusely thank the members of my
committee for their direction, support, and recommendations that allowed me to pass this
project. To my committee chair, Dr. Karen Hessler, thank you so much for the expertise,
guidance, and help in answering my many questions about the capstone project. To my
faculty committee member, Dr. Katrina Einhellig, thank you for giving me motivating
pep-talks and feedback along the way as you also immensely helped me navigate through
the capstone project process. To my community committee member, Maribeth Taylor,
FNP, thank you for your involvement, research experience, and encouragement
throughout the process as you helped me conduct this project. It has truly been a pleasure
and a joy to work with you at your clinic as I implemented my capstone project.
To all my family and friends, thank you so very much for the continuous
encouragement through the years of completing my doctorate and this capstone project.
You all believed in me when I wasn’t sure I could complete this undertaking! I
appreciate your support of my family in watching Elijah, encouraging me, and loving me

v

as I journeyed through this rigorous academic goal. Completing this degree would have
been impossible without you all and for you I am truly grateful.

vi

TABLE OF CONTENTS

CHAPTER I. STATEMENT OF THE PROBLEM ..................................................... 1
Introduction and Background ............................................................................ 1
Population, Intervention, Comparison, Outcome, and Time Statement ............ 5
Review of Literature .......................................................................................... 6
Theoretical Framework .................................................................................... 10
CHAPTER II. PROJECT DESCRIPTION .................................................................. 12
Project Objectives and Timeline ......................................................................
Evidence-Based Project Plan ...........................................................................
Congruence ......................................................................................................
Timeline ...........................................................................................................
Resources ......................................................................................................
Stakeholders .....................................................................................................
Strategic Analysis ............................................................................................

12
14
16
16
17
18
18

CHAPTER III. EVALUATION PLAN ....................................................................... 20
Project Evaluation ............................................................................................ 20
Method Analysis .............................................................................................. 22
CHAPTER IV. RESULTS AND OUTCOMES .......................................................... 23
Results Linked to Problem Statement and Evaluation Plan ............................
Extent to Which Objectives Were Achieved ...................................................
Key Facilitators and Barriers ...........................................................................
Recommendations ............................................................................................

23
31
31
33

CHAPTER V. RECOMMENDATIONS AND IMPLICATIONS FOR
PRACTICE ...................................................................................................... 35
Recommendations ............................................................................................
Contribution to Personal Goals ........................................................................
Five Criteria for Executing a Successful Doctor of Nursing Practice
Final Project .........................................................................................
Summary ..........................................................................................................

vii

35
39
40
42

REFERENCES ............................................................................................................ 44
APPENDIX A. LITERATURE REVIEW FINDINGS TABLE ................................. 47
APPENDIX B. LUNCH AND LEARN EDUCATIONAL FLYER ........................... 50
APPENDIX C. SURVEY ONE ................................................................................... 52
APPENDIX D. SURVEY TWO .................................................................................. 54
APPENDIX E. CONSENT FORM FOR HUMAN PARTICIPANTS
IN RESEARCH ............................................................................................... 57
APPENDIX F. INSTITUTIONAL REVIEW BOARD APPROVAL ........................ 59
APPENDIX G. BANNER HEALTH APPROVAL .................................................... 61
APPENDIX H. STATEMENT OF MUTUAL AGREEMENT .................................. 63
APPENDIX I. CODING HANDOUT ......................................................................... 66

viii

LIST OF TABLES

1.

Comparing Screening Rates Prior to and Before the Seminar ......................... 26

2.

Results of Surveys One and Two ..................................................................... 30

ix

LIST OF FIGURES

1.

Stages of change according to change theory .................................................. 11

x

LIST OF ABBREVIATIONS

AASLD

American Association for the Study of Liver Disease

AHRQ

Agency for Healthcare Research and Quality

APRN

Advanced Practice Registered Nurse

CDC

Centers for Disease Control and Prevention

CINAHL

Cumulative Index of Nursing and Allied Health Literature

DAAs

Direct-acting antivirals

EMR

Electronic Medical Record

HCV

Hepatitis C Virus

PCC

Primary Care Clinic

IDSA

Infectious Disease Society of America

IT

Information Technology

MA

Medical Assistant

MD

Medical Doctor

MeSH

Medical Subject Headings

NGC

National Guideline Clearinghouse

PCP

Primary Care Provider

PICOT

Population/Patient Problem, Intervention, Comparison Outcome, Time

xi

1

CHAPTER I

STATEMENT OF THE PROBLEM

Introduction and Background
Primary care providers (PCPs) have been called the gatekeepers to health care.
Primary care providers are the first to assess a health situation and determine the best
course of action. As such, PCPs need to be well-versed in many diagnoses and plans of
care for such diagnoses as well as be able to provide a thorough well-check or annual
physical. The recently enacted Affordable Care and Safety Act mandates insurances pay
for more preventative medicine to save costs involved in caring for chronic, highlyprogressive diseases and have a healthier population in general. This results in more
people getting annual well-exams and completing preventative and screening healthcare
protocols. Some of these protocols include primary interventions like influenza and
shingles vaccinations and education on healthy lifestyles to try to circumvent disease.
Other secondary surveillance methods include screenings for various diseases as
indicated. Common blood work included in typical screenings at a PCP office are lipid
levels, thyroid tests, and metabolic panels to screen for cholesterol imbalances, hypo- or
hyper-thyroid disease, and glucose and electrolyte imbalances. Other screenings include
colonoscopies, mammograms, and pap smears to screen for colon cancer, breast cancer,
and cervical cancer.
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Most primary care offices adhere well to these screening and prevention
recommendations from the Centers for Disease Control and Prevention and the National
Guideline Clearinghouse (NGC), which is operated by the Agency for Healthcare
Research and Quality (U.S. Preventive Services Task Force [USPSTF], 2013). Many of
these protocols and recommendations were developed by experts in each field as well as
based on meta-analysis of research on the associated topic. Most of these screening
recommendations come from the NGC and are graded upon evidence and outcomes as A
through I--where A is supported by the most evidence and highly recommended with
benefits outweighing risks and I is not recommended as not enough evidence is available
to support implementation (USPSTF, 2013). One such grade B recommendation is for
adults born from 1945 to 1965 be screened for HCV once in a lifetime with a potential
for rescreening based upon high-risk behaviors or receipt of a blood transfusion before
1992. This grade B recommendation is perceived as having moderate net benefit in
preventing further clinical poor outcomes related to HCV as well as preventing further
spread of disease and providing opportunities to teach about this disease process
(USPSTF, 2013).
Hepatitis C virus is spread from bodily fluid contact and is a mostly preventable
disease. According to McCance, Huether, Brashers and Rote (2010), HCV is the most
common cause of chronic liver disease in the Western world; it is contracted through
contact of bodily fluids and 40% of cases are from intravenous drug users (p. 1489). As
such, HCV is largely preventable and now also treatable, especially when detected early.
For the birth cohort of adults in the United States born between 1945 and 1965, it is
recommended each individual be screened for HCV at least once in their lifetime even if
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asymptomatic of liver disease or abnormalities (USPSTF, 2013). The guideline has
determined it to be important for this population to be screened due to high risk for
transmission of disease from possibly receiving a blood transfusion before HCV was part
of the universal screening in blood products and the possibility of transmission from
high-risk behaviors in younger years such as multiple sexual partners, unprotected
intercourse, and/or intravenous drug use (USPSTF, 2013). This birth cohort is at higher
risk for these behaviors partly due to living through the 1970s and 1980s when previously
mentioned high-risk behaviors were a common part of the lifestyle.
It is recommended this birth cohort be screened because untreated HCV can cause
major negative health sequelae for the individual as well as being unknowingly
transmitted to other persons through sexual contact and intravenous drug use.
Undetected and, thus, untreated HCV causes an increased cost load on the healthcare
system to treat the negative health sequalae of HCV disease progression. Proper
screening and treatment helps prevent decreased quality of life for those infected with the
advanced untreated disease. By implementing a screening process for the birth cohort
born from 1945 to 1965, those who received a blood transfusion before 1992, and high
risk individuals, the cost on the healthcare system could be decreased and more adults
could have increased quality of life with less negative health sequelae from HCV.
As an Advanced Practice Registered Nurse (APRN), preventing illness and
limiting negative outcomes from disease process are key to holistic care provided by
nurses. Implementing HCV screening in primary care for the aforementioned
populations is one simple addition to routine health screenings that could have a large
impact on individual health care, a population’s health, and associated healthcare costs.
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Hepatitis C virus is a disease that in its early stages, even in a chronic disease
state, is often times asymptomatic. According to the American Association for the Study
of Liver Disease-Infectious Diseases Society of America (AASLD-IDSA; 2015),
approximately 2.2 to 3.2 million persons are infected with HCV in America and about
half do not know they are infected. To decrease transmission rates and increase
treatments rates, proper screening methods must be adhered to in primary care settings.
Screening for HCV is a simple blood test but is not often offered to patients. This can be
due to lack of knowledge by providers to implement this screening (Bechini et al., 2015),
lack of time in office visits for providers, or lack of knowledge of treatment if results are
positive from a screening test.
The practice setting for the capstone was a primary care clinic (PCC) located in
Greeley, Colorado. This practice has five providers: four medical doctors (MD) and one
family nurse practitioner or APRN. Two of the doctors are full-time at the clinic, one is
there one day per week, and one is an on-call position, filling in on an as-needed basis.
The APRN sees patients four days per week. The clinic cares for adult patients with
chronic illnesses such as chronic obstructive pulmonary disease, diabetes mellitus, and
asthma among other chronic conditions. The providers serve as patients’ primary care
providers (PCP) for well-visits and episodic visits as needed. The PCC focuses on
quality of life for patients through preventive care and management of chronic disease.
This capstone project focused on improving rates of screening for HCV by identifying
and overcoming barriers to screening.
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Population, Intervention, Comparison, Outcome,
and Time Statement
An analysis of current practice of HCV screening in the PCC and many family
practices in the Northern Colorado area found HCV screening for this particular birth
cohort was not routinely offered or completed. Although HCV is not a diagnosis to make
lightly, it is better to diagnose and treat it than let it go unmanaged, leading to chronic
liver disease. By implementing standardized screening mechanisms for HCV for PCPs,
the goal was to identify otherwise undiagnosed cases of HCV to reduce negative health
sequelae and decrease healthcare costs.
Barriers to screening for HCV in primary care include time limitations with
patients, little or no knowledge of HCV screening guidelines, and lack of knowledge of
how to treat a patient with a positive screen. The target population of this capstone was
patients in the birth cohort from 1945-1965 and high-risk patients: those who have in the
past or are currently using intravenous drugs, patients who have been incarcerated,
patients who engage in risky sexual behaviors, and patients who received a blood
transfusion before 1992 (USPSTF, 2013). The researcher evaluated if screening was
completed at well-visits over a three-month time period through a chart review of the
electronic medical record (EMR) for the specified patient population. The desired
outcomes of the capstone were increased rates of screening and identification and
dismantling of barriers to screening for providers. Thus, this project answered the
PICOT question: For patients born from 1945 to 1965, is appropriate screening offered
for HCV routinely at the PCC compared to no screening process to improve screening
rates after implementing a process change in a three-month time span?
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Review of Literature
A literature review was conducted to evaluate current research, barriers to
screening, and solutions to HCV screening utilizing CINAHL and PubMed databases,
UpToDate, the Agency for Healthcare Research and Quality (AHRQ), and text books.
While searching digital search engines, MeSH terms were used including hepatitis C,
mass screening, and costs and cost analysis. This researcher reviewed multiple articles
about this subject matter. The research yielded much information regarding HCV
screening, the benefits of screening that could lead to early treatment, and barriers to
treatment.
Hepatitis C virus is a disease that comes from bodily fluids being shared from an
infected person to an uninfected person. According to Sanjiv, Bisceglie, and Bloom
(2016), chronic HCV is often asymptomatic in many patients or the symptoms can be
vague, e.g., arthralgia and fatigue. Vague symptoms lead to underdiagnoses for many
patients or lack of recognition of an issue to report to the PCP for diagnosis and
treatment. Chronic HCV infection can then lead to cirrhosis of the liver within 20-30
years, the leading cause of liver transplant in the United States of America (Sanjiv et al.,
2016). This deterioration of the liver over time through misdiagnosis or missed diagnosis
increases healthcare costs for patients and the healthcare system while decreasing quality
of life for patients. Treatment of HCV with direct-acting antivirals (DAAs) is becoming
more easily accessible and has revolutionized care of HCV to eradicate it completely
from the host (Brouard et al., 2015).
Negative sequalae associated with chronic HCV infection include cirrhosis, liver
failure with ascites, hepatic encephalitis, esophageal varices, and hepatocellular
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carcinomas (Howie & Hutchinson, 2004). Upon utilizing a computer-generated model,
Howie and Hutchinson (2004) utilized current data of HCV infection rates to estimate a
cost burden of HCV if there was no process change of recognition and treatment of HCV.
The CDC (cited in Howie & Hutchinson, 2004) estimated the direct cost of care for
chronic liver disease in the United States would be approximately $10.7 billion and
indirect costs from associated mortality and morbidity of cirrhosis would be
approximately $54 billion. Although the cost of treatment with the preferred method of
pegylated-interferon and ribavirin is costly, the cost of initial treatment is much less than
the future burden of a large population of undiagnosed HCV patients developing cirrhosis
or hepatocellular cancers (Howie & Hutchinson, 2004). As a comparison of costs from
HCV developing into hepatocellular carcinoma or cirrhosis leading to liver transplant, the
cost of a liver transplant is estimated to be $103,548 and the five-year cost for a person
diagnosed with hepatocellular carcinoma is $106.4 million (Smyth et al., 2014). With the
baby-boomer generation (the birth cohort born 1945-1965) having a high undiagnosed
infection rate for HCV and if the majority of the undiagnosed cases of HCV develop into
cirrhosis, end-stage liver disease, or hepatocellular carcinoma, the cost burden to patients
and the healthcare system could be astronomical.
To prevent the development of HCV into cirrhosis, hepatocellular carcinoma, and
end-stage liver disease for this large population, it is imperative to screen appropriately.
This ensures HCV can be quickly diagnosed and treated with DAAs to eradicate disease
(Smyth et al., 2014). Gane et al. (2015) extrapolated data about aggressive screening,
diagnosis, and treatment rates of 16 different countries. The data showed increasing
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screening and treatment three- to five-fold would dramatically decrease healthcare burden
costs of HCV (Gane et al., 2015).
However, one barrier to adequate screening and, thus, diagnosis and treatment of
HCV is provider awareness of appropriate screening. Bechini et al. (2015) conducted a
semi-quantitative study in six European countries of providers regarding knowledge of
guidelines about screening for HCV. A survey was developed by the researchers and
sent to various healthcare providers with diagnosis and treatment scope of practice to
determine knowledge of screening guidelines for HCV; 56% of the providers surveyed
knew of national guidelines regarding HCV (Bechini et al., 2015). The survey results
also found if providers were screening and received positive results, treatment and
appropriate referral rates were low (Bechini et al., 2015). This exemplifies the need for
increased awareness of screening guidelines as well as appropriate treatment upon
positive screening.
The cost of screening is relatively minimal. A local laboratory in northern
Colorado, Horizon Laboratory (2016), offers direct access testing to any person in
Colorado at a fee-for-service cost of $45; the testing does not require an order by a
provider so a patient might complete tests as desired. This is a minimal cost compared to
possible negative health sequalae related to chronic HCV infection progressing to one of
the aforementioned disease processes. Also, most insurances cover preventative lab work
such as the screening previously discussed. According to Alter, Kuhnert, and Finelli
(2003), laboratory costs to conduct an anti-HCV test are as follows excluding the
payment of laboratory personnel, facility usage, etc.: “$5/sample for initial screening test,
$15/sample for those testing initially reactive and repeated in duplicate,” and “$50-
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$295/sample with reflex recombinant immunoblot assay RIBA and or nucleic acid test
testing (NAT)” (Estimated Costs, para. 4). The reflex testing is lab and provider specific;
however, if a screening anti-HCV test is positive, reflex RIBA or NAT testing must be
completed to confirm positive HCV infection (Alter et al., 2003).
Another factor of HCV screening to consider is the sensitivity and specificity of
the test. When screening is ordered, the USPSTF (2013) recommends Hepatitis C
Immunoglobulin G antibody as the test of choice for chronic HCV. This test works by
testing blood serum for antibodies to HCV in the patient (Sanjiv et al., 2016). Per Alter
et al. (2003), if an anti-HCV test is positive, reflex testing is recommended to confirm a
positive HCV infection. The anti-HCV test is completed with various manufacturers’
machinery utilizing enzyme immunoassays (EIA) or enhanced chemiluminescence
immunoassay (CIA; Alter et al., 2003). When utilizing EIA testing for anti-HCV, the
specificity is >99%; however, among immunocompromised patients, false-positive
results can be as high as 15%. Due to the possibility of false positive, the CDC (cited in
Alter et al., 2003) recommends reflex testing with RIBA or NAT to confirm a positive
screening test.
After thorough appraisal of existing research, HCV screening has proved to be an
effective use of healthcare costs with positive benefit to the patient and healthcare system
as an outcome. The risk of screening is minimal compared to benefits gained from early
identification of disease as are the treatment costs compared to the costs of late stage
disease treatment. As recommended by the AHRQ (2013), routine screening is beneficial
to individual patients, the healthcare population, and the healthcare system. The research
showed evidence that HCV is treatable; the earlier the diagnosis is made, the better the
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prognosis and lower cost compared to late stage disease treatment and care (see
Appendix A for literature review table).
Theoretical Framework
For this capstone project, Lewin’s change theory (Petiprin, 2016) guided the
researcher in identifying barriers to change in the PCC, developing an action plan to
overcome the barriers, and implementing new changes regarding the screening process
for HCV in the birth cohort born 1945-1965. It is important to utilize theory to guide
practice changes as changes within a clinic can be cumbersome to staff and providers
alike. This theory gave a pathway to increase likelihood of acceptance and implication of
changes regarding new practices.
Lewin’s change theory (Petiprin, 2016) utilizes three major concepts: driving
forces, restraining forces, and equilibrium; and three major stages: unfreezing, change,
and refreezing. Driving forces bring changes and shift the equilibrium; restraining forces
hinder and oppose change; equilibrium is a state where no change is occurring as the
driving force and restraining forces are equal (Petiprin, 2016). The stages of change
begin with unfreezing--when old patterns are released and resistance is overcome.
Change is the moving piece; thoughts, feelings or behaviors change the workflow to be
more productive. Re-freezing is when the new habit or process becomes the standard
operating procedure (Petiprin, 2016). Figure 1 shows the change stages.
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Figure 1. Stages of change according to change theory (O’Loughlin, 2013).

Applying the stages of change to overcoming barriers was a challenge as the
barriers for the different providers in the clinic were different. By having an educational
seminar or lunch and learn, this researcher identified whether the clinic valued the role of
HCV screening enough to want to change or unfreeze the patterns regarding HCV
screening and change and refreeze into a pattern that utilizes HCV screening regularly.
The method to change the process regarding HCV screening was also varied depending
on what the barriers were and at what level the changes needed to be implemented, i.e.,
system level or personal level.
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CHAPTER II

PROJECT DESCRIPTION

Project Objectives and Timeline
This capstone project was designed to implement evidence-based practice and
theory into practice. The goal of the project was to improve screening rates of HCV
within the primary care clinic for high-risk populations including the birth cohort
previously mentioned. This capstone project utilized a multiphasic approach to assess
current screening rates, implemented a new process to improve appropriate screening
measures, and re-evaluated screening rates post-implementation of screening tactics.
Project objectives included
1.

Increase screening rates for appropriate patients for HCV.

2.

Identify barriers to screening.

3.

Develop action plan to overcome barriers to screening.

The first objective of this project was to complete a medical record review of the
patients at this clinic to determine if appropriate HCV screening was occurring. This
mainly focused on the birth cohort but also included high-risk patients, which were sorted
from the clinic population using the EMR. The researcher reviewed well-visits within a
three-month period to examine if patients were screened for HCV at the well-visits in the
past, if they met criteria for screening, if they were offered HCV screening, or if there
was a documented refusal of screening. This established a base number of patients at the
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primary care clinic who had been screened or were offered screening. This also showed
if the providers were offering screening appropriately.
Barriers to screening were identified through a lunch and learn for the providers at
the primary clinic provided by this researcher (see Appendix B for flyer). The lunch and
learn focused on guideline recommendations for HCV screening and the importance of
screening for high-risk patients--mainly the patients in the birth cohort (USPSTF, 2013).
After the lunch and learn, the researcher followed up with providers to discuss their
views and opinions regarding barriers to screening if needed. From this lunch and learn,
this researcher developed a plan to follow up on commonly mentioned barriers to assess a
full picture of why HCV screening was not routinely offered or conducted--barriers like
lack of knowledge of how to screen or how often to screen, provider attitude, distrust of
guidelines, time restrictions, etc. The researcher also followed up with personal
interviews as needed to clarify barriers, which allowed the researcher to synthesize which
barriers were possible to overcome and which barriers were insurmountable. Part of the
efficacy and effectiveness of the lunch and learn was measured by a pre-seminar survey
about HCV screening and asking about barriers (see Appendix C), which was followed
by a post-seminar survey (see Appendix D). A consent form for human participants in
research was attached to each survey (see Appendix E).
The third objective of developing an action plan to overcome barriers to screening
depended on what the focus group forum and surveys of the providers revealed as
hindrances to screening for HCV. If it was time constraints of appointments, then
administrative changes could be attempted. If lack of knowledge of what to do after
screening was a barrier that prevented screening from happening, then an education
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session could be scheduled to increase knowledge and comfort with what screening
results meant and how to appropriately treat. As stated previously, overcoming barriers
through an action plan would depend upon the results of the survey and what the followup conversations about HCV screening revealed.
Evidence-Based Project Plan
Completing a chart review of HCV screening at well visits provided a baseline of
screening rates for the primary care clinic. The follow-up lunch and learn discussions
with accompanying surveys helped the researcher discern barriers to screening rates and
guide an action plan for overcoming these barriers to increase screening rates.
Phase One
Phase 1 addressed objective one, which was to increase HCV screening rates for
appropriate patients. The objective entailed obtaining a baseline rate of screening for
well-visits at this clinic to compare later to the post-focus group about barrier rates of
screening. To obtain the baseline to calculate an increase of screening rates, the
researcher reviewed the EMR for all patients in a three-month time period who visited the
primary care clinic for a well-visit for evidence of HCV screening in the past, at the
appointment, or a documented refusal of screening. The patients’ EMR review was for
all patients in the birth cohort of 1945-1965 or a documented history of intravenous drug
use or other high-risk behavior over the age of 18. As this project was focused on
barriers for providers to screening, a simple table was developed.
As the focus of the objective was to help providers increase their rates of
screening, a “yes” response included documentation of previous screening as long as it
was addressed by the provider (this demonstrated awareness of the need for HCV
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screening), a current order of blood work to screen for HCV, and documentation of
discussion of the importance of HCV screening between a provider and a patient.
Phase Two
Phase two addressed objective two--identify barriers to screening. During this
phase, this researcher educated staff and providers of who to appropriately screen for
HCV. This lunch and learn discussed USPSTF’s (2013) guideline recommendation
regarding HCV screening, the importance of appropriate screening, and possible disease
burden reduction that could come from appropriate screening and treatment. During the
lunch and learn, the researcher recorded and took notes regarding providers’ concerns
and questions about barriers that decreased screening rates of HCV as well as utilized
surveys to assess knowledge. The researcher developed and distributed pre- and postlunch surveys to the providers regarding the most discussed barriers to screening as well
as a section on the survey for “other” barriers not included in the survey. The surveys
were further extrapolated for clarification to fully understand and be able to create a
change method for overcoming the barriers.
Phase Three
The third phase of the project addressed objective three--develop an action plan to
overcome barriers to screening. This phase utilized the results of the surveys and
discussions to determine one or two barriers most often recognized by providers to
develop changes to the practice to make screening more feasible at the primary care
clinic. This phase also included implementation of a barrier breaker. After the barrier
change implementation occurred, the researcher waited approximately eight weeks to
reassess if the change was working to increase screening rates for HCV. This
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reassessment was evaluated by a repeated chart review of well-visits from the eight
weeks after the barrier change was implemented. The number of screenings were then
compared to the baseline comparison of EMR reviews captured in phase one.
Congruence
This primary care clinic is part of a larger healthcare system located in the
Western region of the United States of America. The mission of the system is to provide
excellent patient care. Part of providing excellent patient care is to circumvent disease or
decrease disease burden when possible to increase quality of life. Increasing screening
rates for HCV complies with the mission of the organization by decreasing harm to
patients.
Timeline
This capstone project began on December 2, 2016 with a capstone proposal
defense. The researcher obtained approval from the University of Northern Colorado’s
Institutional Review Board to conduct the research (see Appendix F). After this
approval, the project was also approved by the primary care clinic’s organization research
body (see Appendix G); a Statement of Mutual Agreement was also obtained (see
Appendix H).
Phase one was a retrospective chart review of the EMR that began in March 2017.
The retrospective chart review took approximately one month. This was happening
concurrently with phase two that began in March 2017 as well. The lunch and learn
occurred during this time period as well as surveying the providers to discover barriers to
screening practices. Phase three began after the lunch and learn and survey completion in
March 2017. The selected barrier was utilized to create an action plan to overcome it to
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increase screening rates. After implementing the action plan to overcome the barrier, the
researcher waited eight weeks to reassess the HCV screening rates by again utilizing an
EMR review.
Resources
The resources utilized for this project included the providers at the clinic (two
medical doctors and one family nurse practitioner who practice full time and two per
diem doctors), a nurse case manager who helped with chart review and identified highrisk patients, and the office manager and information technology specialists. The
information technology specialists were also good resources for data mining within the
EMR review. Potential barriers to implementing this evidence-based capstone project
included unfamiliarity with the charting system to be able to conduct a thorough chart
review, inadequate time to conduct a thorough chart review, and resistance to HCV
screening by patients. Benefits to conducting this study included increased screening
rates, which could lead to increased identification of HCV and, thus, adequate treatments
to decrease poor outcomes and reduce healthcare costs.
Capstone committee members were also resources who were utilized during the
capstone. Karen Hessler, Ph.D., FNP, MSN, RN was the capstone chair and was vital to
the success of the project. Katrina Einhellig, Ph.D., RN, CNE served as a committee
member and was valuable to research and evidence-based practice changes. Maribeth
Taylor, MSN, FNP, RN served as the outside committee member and was employed at
the primary clinic where the capstone research occurred.
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Stakeholders
Stakeholders for this project included the University of Northern Colorado; the
School of Nursing, the Graduate School, and the committee members for the capstone
were especially invested as stakeholders. At the primary care clinic, stakeholders
included the providers, especially Maribeth Taylor, the FNP onsite; the Medical
assistants (MAs); case managers; and the office manager. The patients also stood to gain
from this capstone as it could circumvent problems via early disease detection and
treatment.
Strategic Analysis
Strategic analysis of the capstone project was through utilization of a strengths,
weakness, opportunity, and threats (SWOT) tool, which allowed the researcher to analyze
how well the implementation of overcoming barriers to screening HCV worked.
Strengths of conducting this project included desire for increased screening rates,
which could lead to increased identification of HCV and adequate treatments to decrease
poor outcomes and reduce healthcare costs. This project also follows a national guideline
developed by experts in the field of hepatology. The capstone also utilized the strength
of conducting research in a clinic part of a bigger system, which offered more resources
to utilize in overcoming barriers.
Potential weaknesses to implementing this evidence-based capstone project
included unfamiliarity with the charting system to be able to conduct a thorough chart
review, inadequate time to conduct a thorough chart review, resistance to HCV screening
by patients, and resistance by providers to implement changes.
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Opportunities within this capstone included increased quality of patient care,
increased provider satisfaction and safety in following appropriate guidelines, and
potential decreased burden on the healthcare system. Threats to the capstone included
provider resistance, time constraints, and possible resistance to learning and changing
habits.
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CHAPTER III

EVALUATION PLAN

Project Evaluation
The objectives of the capstone were to increase screening rates for appropriate
patients, identify barriers to screening, and overcome barrier(s) to increase screening
rates. The project was evaluated in three phases over approximately five to six months.
Phase One
Initial surveillance of the program included a medical chart record review of three
months’ worth of well-visits for all providers at the primary care clinic. The table
depicted in Figure 2 in Chapter II served as the data collection tool for the EMR review.
During this EMR review, a systematic review surveyed for appropriate patients to screen
for Hepatitis C. These appropriate patients included the birth cohort of people born
between 1945 and 1965 per the target population of the guideline (USPSTF, 2013).
During this EMR review, the table’s category of HCV screening ordered included
information about whether the patient was offered screening with the provider at the well
visit and thus completed. The results were interpreted as percentages of screenings
offered and completed. The screening rates were determined by comparing total
population of well-visit patients seen by providers in the three-month period in the birth
cohort surveyed by this researcher. The researcher then created percentages of the pre-
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and post- educational seminar surveys to analyze the data pulled from the EMR at the
primary clinic.
Phase Two
As previously stated, a lunch and learn was facilitated by this researcher regarding
the importance of HCV, which patients were appropriate for screening, and appropriate
treatment to follow upon a positive screen. Following the short educational forum, this
researcher followed up with discussion of perceived barriers to screening at the clinic.
This discussion was reviewed by this researcher who utilized a follow-up survey to delve
deeper into why the issues were barriers to implementing HCV screening. The survey
also included room for other barriers not mentioned in the forum to be accounted for so
this researcher could have a full picture of what barriers prevented appropriate screening
from occurring.
Phase Three
After teaching about the NGC (USPSTF, 2013) guideline and surveying the
providers at the primary care clinic, the researcher selected one barrier to screening rates
and developed an action plan to overcome that barrier to improve screening rates. The
action plan depended on the lunch forum discussion of barriers and the post-seminar
survey to address the most common barriers. After implementing the action plan to
overcome the barrier, the researcher waited eight weeks to allow the action plan to be
implemented and change the screening process at the primary clinic. After the eight
weeks, the researcher re-surveyed all well-visits within this time span for a medical chart
review regarding the rates of appropriate screening for patients seen at the primary clinic.
The table depicted in Figure 2 was once more utilized to provide descriptive data about
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screening rates. The descriptive statistics were then compared to pre-implementation
rates collected in phase one. This statistical comparison showed an increased percentage
of screenings, thereby successfully overcoming the barrier identified by the researcher
and the providers.
Method Analysis
To provide statistical significance to this project, data recorded from the chart
survey were analyzed and converted into a percentage of patients screened compared to
the number of patients who met criteria but were not screened. This provided a baseline
of potential screening opportunities missed. As previously mentioned, a similar medical
chart review was also conducted after the education when barriers were identified and
overcome. The desired statistics were gathered using the data collection table.
To evaluate the process of identifying barriers and overcoming them at the
primary care clinic, nursing change theory was used to evaluate the practice change in the
phase it now resided. Although, a specific framework was not used to apply the statistics,
the database created and maintained from the pre-barrier breakdown implementation
versus the post-barrier breakdown period provided numerical value to the statistical and
clinical significance of the HCV screening process in the primary care clinic.
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CHAPTER IV

RESULTS AND OUTCOMES

The objectives of this capstone project were to increase screening rates for HCV
in the 1945-1965 birth cohort at a primary care clinic in Northern Colorado, identify
barriers to screening in a primary care clinic, and overcome barriers to improve screening
rates. This chapter presents the results of the planned evaluation as outlined in Chapter
III. To meet the objectives, this researcher utilized an EMR review of patients seen in a
three-month time period before the lunch and learn seminar who met the criteria of being
born in the birth cohort to check for a baseline screening rate. This method helped to
determine baseline screening rates in order to have a rate to compare to the post-lunch
and learn seminar and implementation of an action plan to increase screening rates.
Results Linked to Problem Statement
and Evaluation Plan
On March 8, a lunch and learn educational seminar was given to the providers and
staff at the clinic. Two weeks prior to the seminar per discussion with the manager, a
date was set for the seminar and all clinical staff and providers received an email from the
manager regarding the date and time of the lunch. Prior to the seminar, the researcher
met with the nurse practitioner who was part of this capstone project committee and the
clinic manager to discuss potential barriers at the clinic in order to be better prepared for
the seminar. Concerns included time spent with patients and mainly a billing and coding
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concern. Per the manager, screening diagnosis codes assigned to screening lab orders,
like the Hepatitis C antibody test, were not being accepted by Medicare as valid codes for
screening and preventative testing. Patients were then getting charged for the lab testing
when usually screening lab work is covered by insurance companies. This created a
challenge in how to bill and appropriately code for screening lab work like the HCV
antibody test.
As previously stated, a chart audit of the EMR was performed on all well-visits
for patients in the birth cohort for a three-month time period prior to the lunch and learn
seminar and the subsequent action plan at the primary care clinic. To get an accurate
random sample of patients from the birth cohort, a list was compiled of all patients seen
by the five providers at the clinic in the three-month time period. The majority of the
patients were seen by two doctors of the five providers who work at this clinic full time,
followed by patients seen by the full-time nurse practitioner; a small amount of the
patients was seen by the other two doctors who were only at this clinic one to five times
per month depending on the scheduling needs of the clinic. This query for patients
initially totaled over 2,200 patients. This list was then sorted by “schedule reason,”
meaning the reason the patients scheduled the appointment. For this chart audit, all
episodic, acute, or “sick” reason appointments were excluded from the chart audit. This
left all patients scheduled to see a provider based on the reason of well-visits or annual
physical appointment. The list was then further limited by the age of the patient. All
patient charts were removed from the list of potential audits if they did not meet criteria
of being born between 1945 and 1965. For the three-month period, 124 patient charts
remained to be audited.
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According to the manager of the clinic, the total number of established patients at
the clinic who are in the birth cohort was 317 (Personal communication, 2017). The total
number of patients within the birth cohort (born from 1945-1965) was 317. The sample
population of well visits between November to January was 124 patients. This meant
approximately 39.1% of the total birth cohort population at the clinic was represented in
the chart review. Of the 124 patient charts that were audited for whether HCV screening
was completed, 47 of the patients were screened within the last two years for HCV or
were able to verbalize a negative screen in the past and the provider documented as such.
This yielded a 37.9% positive screen rate for the sample of the birth cohort seen by
providers at well visits for a three-month period.
For the data collection from the EMR, the time period of the three months prior to
the lunch and learn, the data review sample population was limited to just patients who
came to the clinic for a well visit. Hepatitis C virus screening could be ordered and
completed at any appointments other than a well-visit. The review of well-visit data
revealed one of the three main providers consistently included discussion and offering of
HCV screening to the birth cohort; the other two main providers either did not document
the discussion or did not offer it to their patients. During the three-month time frame, the
two part-time providers at the clinic worked a total of 10 days each; thus, a majority of
the patients were seen by the three main providers. After the lunch and learn seminar,
one of the part-time providers resigned from the clinic. The two part-time providers did
not consistently offer, document, or discuss HCV testing for patients in the target
population during well visits.
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For the post lunch and learn eight-week chart review, the sample size of the total
birth cohort was 45. Therefore, the sample population was 14.19% of the total birth
cohort at the clinic. The chart review revealed that 31 of the 45 well visits in the birth
cohort were screened for HCV at their well-visit. Having 31 patients screened yielded a
68.89% screening rate for patients within the birth cohort. The screening rate prior to the
lunch and learn was approximately 37.9%. This was a 30.99% increase in the sample of
the birth cohort being screened for HCV. Table 1 shows the results of the screening rates
prior to the lunch and learn seminar compared to the post seminar screening rates after
addressing the barrier of coding.

Table 1
Comparing Screening Rates Prior to and Before the Seminar
Prior to Seminar

Post Seminar

Total Patients Reviewed

N = 124

N = 45

Patients Screened for HCV

N = 47 (37.8%)

N = 31 (68.89%)

While also discussing information with the manager and NP at the clinic
regarding potential barriers preventing HCV screening, the researcher found the common
barrier for HCV screening was the billing and coding issue. From this information, the
researcher developed two surveys for use at the lunch and learn seminar to evaluate
understanding of the topic. The researcher also developed two handouts for the staff at
the seminar that educated about HCV screening and potential coding information to assist
in ordering the screening. The coding informational handout was developed by the
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researcher with consultation from the coding specialist onsite for the clinic. Survey 1 can
be found as Appendix C. Survey 2 can be found as Appendix D. The coding handout
can be found in Appendix I. The HCV informational handout can be found in Appendix
B. Survey 1 was given to all in attendance before beginning the seminar and collected by
the researcher. Then the handouts were given to all attendees and the researcher gave a
short presentation about the HCV screening guideline pertaining to the birth cohort and
allowed time for questions. The intervention discussed to help improve screening rates
was in relation to coding appropriately. The coding handout was referenced. All in
attendance were allowed to ask clarifying questions and verbalized understanding of the
improved coding options. Following the presentation of information and answering of
questions regarding the coding process, the researcher gave all attendees the second
survey. In total, the meeting attendees included the three main providers of the clinic, the
clinic manager, a laboratory technician/phlebotomist who is a full-time employee of the
clinic, and three medical assistants (MAs) for a total of eight participants.
Preliminary barriers identified from the discussion at the seminar revealed mainly
concerns about how to code the appointment appropriately for the screening tests to avoid
patients being billed directly for the screening. After discussing the handouts that
included helpful coding information, all attendees verbalized no further questions at this
time and agreed that HCV testing should be offered to any patient who met criteria. All
in attendance were able to successfully identify the correct test for HCV screening (HCV
antibody) and which patient population met guideline recommendations for once in a
lifetime screening (birth cohort from 1945 to 1965).
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Survey data was compiled by the researcher. Survey 1 had eight completed
surveys returned to the researcher. Only seven of Survey 2 were returned to the
researcher. Table 2 shows the results from Surveys 1 and 2. Question 1 addressed the
confidence level of the attendees to identify screening methods for HCV. A 5-point
Likert scale was used to determine confidence levels where 1 = Not confident at all and 5
= Very confident. The pre- and post-seminar confidence levels showed an increase from
3.25 to 4.714, respectively, when averaging all the survey results. Question 3 addressed
confidence with identifying a positive screen result. Although the purpose of the lunch
and learn was to increase screening rates, it was important for providers to have the
knowledge of what the next steps were for a positive screening in order to get treatment
for patients to prevent the poor outcomes previously discussed related to chronic HCV.
The seminar had a positive impact on the confidence levels of identifying positive HCV
screening results as evidenced by the increased Likert scale. The pre-seminar scale score
was 3.25 and the post-seminar scale score was 4. Question 4 addressed next steps if a
positive result was discovered. The seminar was effective on this topic as well for this
question as answers remained correct. Question 5 addressed referral resources for
treatment for positive HCV screens. On the pre-seminar survey, four of the eight
responders left this question blank but after the seminar, all seven responders answered to
refer the patient to gastroenterologists or gastrointestinal specialists. Questions 6 and 7
were free text answers regarding motivators for the attendees to screen their patients for
HCV and barriers preventing screening patients for HCV, respectively. Answers can be
seen in the table. However, especially with regard to the barriers, repeated answers
revealed reimbursement, insurance, and coding problems were common. Patient choice
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was also a barrier listed that could be addressed through education. However, at this
time, the researcher focused on the more prevalent answer related to coding and
reimbursement costs for patients. Another barrier that could have been addressed as
evidenced by one answer, “not listed in health maintenance section of chart,” is addressed
later in this capstone but was not addressed as a barrier during the research and
implementation phase of this project.
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Table 2
Results of Surveys One and Two
Question

Survey 1 (Pre-Seminar)

Survey 2 (Post-Seminar)

1. Confidence level with screening
for HCV (1=not confident at all,
5=very confident)

3.25

4.714285714

2. Test to be ordered to screen for
HCV

HCV antibody (100% of surveys
had correct answer; one also put
hepatitis panel as a second
answer)

HCV antibody (100% of surveys had
correct answer)

3. Confidence level with
identifying an abnormal HCV
value (1=not confident at all,
5=very confident; average score in
results box for survey 1 and 2)

4

4. If a screen for HCV is found to
be abnormal, what are next steps?

call pt and call GI, ?,HCV RNA,
HCV genotype, viral load, HCV
PCR, refer to GI

refer to GI, viral load, viral load PCR,
HCV genotype/RNA

5. What are the referral resources
in this area for diagnosis of HCV?

4 of 8 surveys left blank, others
answered GI referral

refer to GI (response from all 7 surveys)

6. Top 3 motivators for you to
participate in screening for HCV?

"right thing to do," great pt care,
to help pt, age/demographic,
lifestyle, possible exposure,
symptoms, early identification/
referral/treatment, task force
recommendation, pt agreement,
disease finding, improved pt
outcomes, reduce risk of liver
cancer, reduce transmission,
further, education about HCV,
what to expect if dx with HCV

age group, early dx, avoid/prevent
complications of chronic liver disease,
education/knowledge, educating
patients, patient care, good pt care,
identify disease, treat disease, US task
force recommendation, improve pt
outcomes, worsening of pt conditions,
reduce carrier co-infections

7. What are the top 3 barriers that
may keep you from screening for
HCV?

"my mind," not listed in health
maintenance section of chart,
insurance, cost/no insurance, not
being aware of the need,
insurance, patient unwillingness
to be screened, insurance not
covering testing, pt not wanting
testing, time availability,
reimbursement, time, pt
willingness, "I don't test patientsnot a provider," cost/no insurance

coding for reimbursement, insurance,
treatment decisions, "not a provider,"
coverage-insurance, patients not
wanting testing, stigma, coverage, pt
doesn’t want testing, time,
reimbursement, pt choice, time,

8. What was the most useful part of
the educational program today?

n/a on part 1

9. How could the program be
improved to better serve your
needs?

n/a on part 1

reinforcing importance of screening,
codes to help with screening diagnosis
coverage, refresher/classifying need of
screening baby boomers learning about
HCV
"you did awesome", visuals
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Extent to Which Objectives Were Achieved
It is clear the objectives of this capstone project were achieved. The providers
agreed at the lunch and learn that screening this birth cohort per the national guideline
was important and barriers were identified and addressed to help increase the screening
rates. The researcher of this project saw an increase of more than 30 percentage points in
the screened population. However, the sample size for the post-lunch and learn screening
rate evaluation was much smaller. This could have been due to providers taking time off
from work during the time frame so there were less patient appointments in total.
Addressing the barrier of coding seemed to be effective in helping providers code
appropriately for screening of HCV. This researcher assumed patient screening rates
would continue to improve over time as the providers refreeze their new habit to include
HCV screening as part of annual lab work addressed at well-visits. As the providers
refreeze their screening habits, hopefully the entire population of patients that meet
criteria for screening will be screened. If the data review process of ascertaining if HCV
screening was offered and completed continued over the next year, the researcher
anticipates the rate would continue to increase as patients complete their annual well
visits over the next year.
Key Facilitators and Barriers
Key facilitators of the capstone project included the primary care clinic manager
and the three main providers at the clinic who agreed to screen the population based on
the guideline (USPSTF, 2013). The three providers who attended the lunch and learn
agreed to screen and found the handouts helpful in ordering the testing with the
appropriate codes for the birth cohort. The fourth and fifth providers who were not
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regular, full-time providers at this clinic did not attend or verbalize their agreement but it
did not appear their rates greatly impacted the results of this project. One provider
resigned from the clinic before the post lunch and learn review. The other provider only
assessed patients during three days of the eight-week period and none of her patients
were there for a well-visit. Although the barrier addressed was coding appropriately for
the screening test, the researcher did not evaluate the codes used before and after the
lunch and learn seminar to code for the HCV testing.
Another key group of facilitators to this capstone project included the MAs who
were in attendance at the lunch and learn. By having them attend the lunch and learn,
their knowledge of HCV screening and its importance would help in answering questions
for patients. The MAs and laboratory technician in attendance at the education seminar
could also better understand the next steps for positive results should they arise and help
direct the patients appropriately to their providers. The MAs could also send a letter or
call patients with normal (negative lab results) or schedule the patients with the providers
in the case of a positive result to complete the next steps.
This researcher was also a key facilitator in this quality improvement process at
the primary care clinic. She spent 40+ hours completing chart reviews on patients at the
clinic for well-visits, planning and executing the lunch and learn, and speaking with the
staff to follow up on and identify barriers to screening. She also created ideas to address
these barriers that were sensible to this particular clinic (i.e., creating a handout about
coding appropriately). The researcher was also on site and available to the providers and
staff to answer any questions or clarify information about the HCV screening and
guideline. This researcher realized objective one addressing increasing screening rates
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could have been increased even more by utilizing the EMR to create a screening reminder
for providers seeing patients at their well-visits. Although no major barriers were
encountered during this project, one barrier the researcher identified post-EMR chart
review that might have deterred providers from screening was the use of formatted smart
text. All the providers used a pre-made format of questions and objectives to address
with patients at well-visits and unless the pre-made format included screening for HCV, it
was not often addressed. Two of the providers utilized a smart text that included
addressing HCV screening and one did not. This appeared to impact screening rates for
HCV for this provider.
Recommendations
In summary, the researcher found this capstone project was beneficial and
successful regarding the objectives of increasing screening rates for HCV and identifying
and overcoming a barrier that decreased screening rates in the birth cohort. All the
providers and the clinic manager found this project to be useful in improving the quality
of care provided to the patients regarding screening for HCV in the birth cohort. The
providers made strong efforts to offer HCV screening and document screening choices
made by the patient to increase screening rates for HCV. In the future, educating the
providers regarding the use of formatted smart text to help prompt asking patients about
screening for HCV could be a helpful tool to improve screening rates. An EMR chart
reminder could also be utilized to increase screening rates.
The researcher did not identify unintended consequences of the capstone project
but as anticipated, the screening rates for HCV in the birth cohort did improve
significantly in the eight-week post lunch and learn period. The researcher assumed the
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screening rate would increase more after the lunch and learn seminar and address the
barrier of coding with a tip sheet (see Appendix I). She anticipates the screening rates
will continue to rise as providers refreeze their habits of including screening for HCV in
the birth cohort. As previously stated, the researcher noted a 30% increase in screening
rates of the sample birth cohort in the eight-week period of patients screened after the
lunch and learn seminar compared to the previous chart review. After completing the
eight-week period of chart reviews post lunch and learn, informal discussion with the
providers yielded information that indicated providers were changing habits to always
include screening for HCV. However, in reviewing the progress notes associated with
the well-visits, documentation was not consistent between providers about whether
patients refused HCV screening. Providers did not consistently document their
discussion of HCV screening within the patient’s chart. In the future, having smart text
formatting that includes screening discussion surrounding HCV would help clarify if
patients were refusing based on lack of knowledge, previous screening, or other reasons.
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CHAPTER V

RECOMMENDATIONS AND IMPLICATIONS
FOR PRACTICE

The objectives of this capstone project were to increase screening rates for HCV
in patients born between 1945 and 1965 at a primary care clinic in northern Colorado by
identifying and addressing a barrier that hinders providers from screening this birth
cohort. These objectives were executed utilizing three main methods:
1.

Investigated barriers that hindered providers from screening patients for
HCV.

2.

Utilized a lunch and learn educational seminar about HCV that included
surveys about barriers.

3.

Addressed the barrier of coding properly with a handout for providers and
clinical staff with information about how to code properly for lab work to be
completed.

In this chapter, the researcher provides recommendations for the primary care clinic
about how to further increase screening rates and how the project would likely prove to
be beneficial if screening rates for HCV continued to increase.
Recommendations
This researcher recommends the project conducted on increasing HCV screening
rates for the birth cohort born between 1945 and 1965 continue into the future. Although
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the lunch and learn educational seminar about the national guideline regarding screening
for HCV in the birth cohort (USPSTF, 2013) was a one-time event, the addition of the tip
sheet found in Appendix I for all providers at the clinic could be helpful in reminding
them about the importance of screening for HCV the birth cohort. This would help
prevent future poor outcomes associated with undetected chronic HCV infections. This
researcher makes the following recommendations to improve screening rates for HCV for
the birth cohort:
•

Educate and encourage all providers, existing and new, at the clinic to
include HCV screening for the birth cohort born between 1945 and 1965 in
the smart text format of items to review with patients who come to the clinic
for well visits; and encourage documentation of either a past screening, a
patient refusal of screening after discussion with the provider, or a lab order
placed to have the patient screened for HCV.

•

Use the EMR program to generate an alert reminder for the MAs to ask
patients about HCV screening before the providers see the patient to help
with the barrier of time with patients. After the educational seminar, MAs
can feel competent to at least ask patients if they are interested in this
screening as the purpose for the screening was made known.

•

Utilize the “health maintenance” section of the EMR that helps providers
and MAs ensure patients are up to date on various tests and immunizations
by creating a HCV screening reminder under the “health maintenance” tab
to be addressed at all visits by either the provider or the MA.
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After implementing this capstone project, it was easy to see that changes in
behavior patterns and refreezing habits take time. Although the national guideline
(USPSTF, 2013) regarding HCV screening in the birth cohort born from 1945 to 1965 is
not a brand-new guideline to implement, it takes time to integrate any changes into
practice. If this capstone project were to continue over time, it is the researcher’s
expectation that the providers and MAs would refreeze habits to include always asking
patients in the birth cohort about screening for HCV at well visits just as many other
health maintenance items are routinely addressed at well-visits, e.g., being up to date on
vaccinations. To add an alert or reminder in the EMR under the “health maintenance”
section of the EMR would add an automatic-type screening similar to always asking
patients at well-visits about their screening mammograms or other blood work to check
for diabetes or high cholesterol. Most providers, as observed by the researcher, have
frozen habits to include this kind of screening routinely and do not generally need an
EMR alert or reminder. At this time, the phases of the capstone project are completed.
The researcher has no further plans for evaluation or improving processes regarding HCV
screening outside of this project at this time.
As the mission of the system is to provide excellent patient care, the screening of
all patients born between 1945 and 1965 for HCV at least once in a lifetime per the
National Guideline Clearinghouse (USPSTF, 2013) is both feasible and beneficial to
patients and meets the mission of the system. Although it is a change of habit and
perhaps even increases workload for the providers and MAs initially, the long-term
benefits of HCV screening far outweigh any risks for an individual patient at system and
population levels. The positive identification and referral of patients infected with
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chronic HCV to a gastroenterologist for treatment has many long-term benefits for
patients. Treatment of HCV can prevent poor outcomes and health disparities related to
chronic HCV infection like liver cirrhosis, cancers, and need for transplant (Sanjiv et al.,
2016). If the project was to continue, perhaps a continued education for staff could be
completed as a refresher by one of the providers or the office manager so all staff stay up
to date on protocol for screening and treatment if a positive result is yielded.
As the primary care clinic is part of a bigger healthcare system, this capstone
project could definitely be applicable to other primary care clinics within this system. As
previously stated, the NGC (USPSTF, 2013) recommends screening all patients born
between 1945 and 1965 for HCV once in their lifetime. After completing chart reviews
of the EMR of a sample of patients born in the birth cohort at the primary care clinic, the
researcher found there was no standard procedure or approach to ensure all patients who
call the primary care clinic their primary care office were being screened. The researcher
found it easy to extrapolate this finding of lacking a standard procedure to other primary
care clinics in the area, within the healthcare system, and even clinics located throughout
the nation. Per the NGC, this recommendation to screen all people born between 1945
and 1965 is necessary and valuable to contributing to a healthier individual and
population. To make screening more likely to happen on a large-scale level, educational
seminars like the lunch and learn conducted at this primary care clinic could be
conducted including the handouts to help educate all providers and MAs who care for this
population. It is important to educate providers since an early identification of positive
results for a patient could mean complete cure rate for the majority of patients, which
lessens the risk for liver disease, cancer, and need for transplant (Sanjiv et al, 2016).
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Contribution to Personal Goals
This capstone project contributed to the researcher’s personal goals regarding
development into a nurse leader and advanced practice nurse. This project exemplified
the researcher’s ability to identify an area lacking standard procedure based on evidence
about screening for HCV in the birth cohort, disseminate information about the
recommendation, and help create new habits for providers and clinical staff to increase
quality of care provided at the clinic. All of these abilities were utilized specifically as
related to chronic HCV infection and the ramifications of untreated disease but could
easily be transposed to other evidence-based practice guidelines to improve quality of
patient care. The researcher was organized, systematic, and attentive to specific needs of
the primary care clinic in carrying out this capstone project to fruition. The researcher
expects that as the providers continue to increase screening rates for their patients, other
clinics will begin to do the same within the healthcare system as evidence-based practice
is an ever-important part of providing quality care for patients. In looking to the future as
an advanced practice provider, this researcher is confident in being able to implement
other similar evidence-based information into practice after completing this capstone
project. This primary care clinic is part of a healthcare system that strives to be
innovative in providing quality and up to date care. The researcher hopes the practice
will continue to increase in screening rates for HCV as well as further disseminate
information about the importance of screening for HCV in the birth cohort born between
1945 and 1965. The researcher hopes this kind of welcome reception to implement
evidence-based guidelines and practice into practice for the best care of their patients
becomes the standard for all primary care clinics.
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Five Criteria for Executing a Successful Doctor
of Nursing Practice Final Project
In 2014, Waldrop, Caruso, Fuchs, and Hypes wrote EC as PIE. This article
describes five criteria for executing a successful Doctor of Nursing Practice (DNP)
project. By meeting the five criteria in a final DNP project, the student has met the
outcomes of the essentials of doctoral education in advanced practice nursing as
described by the American Association of Colleges of Nursing (cited in Waldrop et al,,
2014, p. 300). The letters EC as PIE stand for enhance, culmination, partnerships,
implements, and evaluates (Waldrop et al., 2014). Each of these criteria is discussed in
relation to this researcher’s capstone project.
The “E” stands for “enhances health care outcomes, practice outcomes, or
healthcare policy” (Waldrop et al., 2014, p. 301). This capstone project enhanced current
healthcare by utilizing the nationally recognized guideline of screening all patients born
1945-1965 for HCV to improve patient care and decrease healthcare burden at a personal
level and at a system level. The project analyzed current literature to guide project
implementation and sought a better outcome for patients through implementing evidencebased practice.
The “C” represents a culmination of practice inquiry and expertise (Waldrop et
al., 2014). The capstone project showed culmination as this researcher has become an
expert on the subject matter of HCV screening, repercussions of untreated chronic HCV,
and next steps to follow when a positive screen is identified from a screening. The
researcher used information gained from the DNP program and courses to integrate
evidence into practice. The project interfaced with the EMR through the use of data
collection and could further use the EMR to improve screening rates with expertise
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consultation with information technology experts. After further discussion with the
manager of the clinic, the use of EMR task reminders to screen for HCV is a possibility
to be further explored.
The “P” stands for partnership and engagement within interdisciplinary teams or
collaboration within interprofessional teams (Waldrop et al., 2014, p. 302). From the
project process, this researcher worked with various members of the primary care team.
The laboratory technician, the MAs, the coding expert, and the clinic manager were all
vital parts of the research process. The researcher also discovered medical specialty
groups in the northern Colorado area for referral of positive HCV screening results.
The “I” stands for implementation. Implementation could also be application or
translation into practice (Waldrop et al., 2014, p. 302). As discussed, this researcher saw
a gap in screening efforts at a clinic level and implemented a new practice of screening to
improve screening rates. This was applicable at the clinic level and if screening levels
increase at more than just the single clinic, it could have population and system-wide
benefits. Translating the evidence of increased screening rates for HCV to a system level
can have huge savings to the healthcare system in a monetary sense and a population
health sense.
The final letter “E” from EC as PIE stands for evaluation of healthcare practice
outcomes (Waldrop et al., 2014, p.302). The evaluation criteria were met by increased
data percentages of patients being screened at this clinic for HCV. The researcher
utilized a two-fold EMR review to evaluate a clinic level change and show an improved
outcome. The long-term outcomes of increasing screening rates are harder to monetarily
account for but the literature review and data showed the outcomes of increased

42
screening allowed for increased treatment of chronic infection of HCV to decrease
mortality associated outcomes.
Summary
Hepatitis C virus screening in the birth cohort born between 1945 and 1965 is a
Grade B recommendation from the National Guideline Clearinghouse (USPSTF, 2013)
and well worth the effort in primary care clinics for individual patients as well as the total
population. This capstone project was successful per the researcher’s evaluation as
screening rates for HCV drastically increased following a lunch and learn educational
seminar and a barrier preventing screening was successfully identified and overcome
through the use of an informational handout. There is little risk and much to gain for
other primary care clinics to begin routinely screening this birth cohort for HCV as the
patients who screen positive could be treated to prevent individual costs both physically
and fiscally as well as decreasing burden on the healthcare system as a whole. The
researcher viewed this project as successful based on the increase in screening rates and
the overall increase in knowledge of providers regarding HCV as evidenced by the
survey responses. After conducting the second eight-week chart review, the researcher
found smart text formats that helped guide providers in their topics to discuss with
patients at a well-visit had a large impact on whether or not HCV screening was
addressed. If the EMR and specifically smart text formatting or targeting productive use
of the EMR as a reminder tool for HCV were utilized, rates of screening could increase
even more in the future. However, the researcher enjoyed seeing this project come to
fruition as she honed her leadership and advanced practice skills as she prepared to
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become an advanced practice provider in a similar setting to the primary care clinic
where this project was implemented.
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Hypothesis

Objectives

Questions

Variables

Design

AASLD/IDSA
HCV Guidance
Panel (2015)

This study was
done to create
recommendations
for the screening
and treatment of
HCV.

Do providers
appropriately
screen for
HCV and
follow up with
appropriate
treatment?

No variable,
just
recommendati
ons.

No design method,
just
recommendations.

Bechini et al
(2015)

Training and
implementation
of HCV and Hep.
B guidelines for
screening is very
important for
providers.

Screening of birth
cohort and high
risk populations.
Screening done per
FDA approved
testing method.
Annual testing for
IV drug users.
Educate about liver
damage prevention
for patients with +
result. Prompt
treatment of HCV
positive patients by
qualified providers.
Antiviral Tx
recommended for
all patients with tx
regimens.
Discover if training
and guidelines are
available and
utilized by
providers regarding
HCV and Hep B
screening.

Do providers
adequately
screen for
HCV and
HBV?

Guidelines
vary by
country.

This was a metaanalysis of
guidelines in
databases and
disseminated to
providers and
whether training
was available on
when to use.

Brouard et al
(2015)

Estimate of
prevalence of
HCV positive
individuals who
do not know
infection status
and increase

Comparative data
of 2004 prevalence
of HCV status and
knowledge of
status with 2014
data.

What can be
done to
increase
screening rates
of HCV in
appropriate
populations to

Screening
processes
from 2004 to
2014 have
changed.

Data surveillance

Sample
setting
n/a

Findings

A literature
review was
performed
followed by
a survey of
healthcare
professional
inquiring
about the
knowledge
of HCV
screening
practices.
n/a

Further education
is needed for
health care
professionals re:
HCV screening
and treatment
practices and
protocols.

Other
commentary

Same as stated in
objectives. All
patients with
positive HCV
should be treated
promptly to
prevent further
health
deteriorations and
costs to patients
and health care
system.

A new screening
strategy in France
can increase
diagnosis rates,
but more
availability is
needed for
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Author(s)
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Gane et al
(2014)

Howie and
Hutchinson
(2004)

Smyth et al
(2014)

screening
practice to
increase
diagnosis and
treatment.
Can increased
screening rates
help to decrease
the disease
burden of HCV?

If HCV virus
rates increase at
current rates,
disease burden
and prevalence
will increase
disproportionatel
y to cost of
treatment.
The cost
comparison of
treatment of
HCV versus the
cost of clinically
significant
disease of HCV
makes early
diagnosis and
treatment a
promising
venture.

properly
diagnose and
treat HCV?

How will HCV
screening rates
change the
population
outcome of
disease in birth
cohort and high
risk
individuals?

To show that the
disease burden of
HCV is significant;
there is major
benefits to
adequate screening
and thus,
treatment.

IS there
enough
resources to
screen and treat
appropriate
populations?

Provide real world
cost estimates of
ambulatory
management of
early to moderate
stages of HCV
compared to end
stage and severe
HCV clinical
manifestations to
show the relativity
of price of
treatment to
prevent chronic
liver disease.

Is treatment
feasible to
prevent costs
and mortality
and morbidity
of late stage
liver disease
from HCV?

A model to
forecast HCV
disease
burden to
attempt to
measure
prevalence,
treatment, and
therapy
options.
No variable,
just predictive
values

The use of a
forecast model
shows that an
increase in
successful
diagnosis and
treatment for a
small population
will decrease
disease burden.
n/a

Fifteen
countries.

Disease burden
can be reduced by
appropriately
screening and
treating HCV.

n/a

Variable is
cost of
clinically
significant
illness of
HCV patients
compared to
cost of
treatment.

Cross sectional
study in Ireland.

Patients in
Ireland.

HCV is costly to
the health care
system and to the
patient. However,
burden of liver
cirrhosis in the
next 10-20 years
is more costly
than treatment.
Current treatment
costs of HCV are
expensive, but
comparatively to
the costs of end
stage liver disease
and complications
of untreated
HCV, the costs of
early treatment
make screening a
worthwhile
endeavor.

Although
disease rates of
HCV have gone
down, it is
estimated that
many patients
do not know
their disease
status and will
not until they
become
symptomatic
with liver
failure.
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Descriptive focus
of showing the
disease burden of
HCV rates
increasing without
further screening.

treatment upon
further
examination.
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Consent Form For Human Participants In Research
University of Northern Colorado School of Nursing
Project Title: Hepatitis C Screening in Primary Care
Researcher: Elizabeth Cirbo, BSN, DNP-S

Email: cirb3015@bears.unco.edu

Research Advisor: Karen Hessler, PhD, FNP

Email: karen.hessler@unco.edu

Phone #: 970-351-2137
Purpose and Description: Thank you for participating in this survey. These questions
concern basic clinician knowledge regarding screening for Hepatitis C Virus in primary
care. The purpose of the survey is to further evaluate process improvement outcomes as
part of a DNP Capstone. Participation in this survey has no anticipated risk or
inconvenience to you, and should only take about 5-10 minutes of your time.
Once the study is completed, results will be shared with you if you desire. There is no
anticipated risk outside of what might occur in everyday interactions associated with
completing the surveys and there will not be any compensation for doing so. There is no
direct benefit to being in the study but you may help increase quality of patient care.
Your consent form will not be stored with your responses, and your name will not be on
your surveys to help protect your anonymity. The survey’s will be kept in a locked office
in the school of nursing separated from your consent forms, only accessible by the
researcher and research advisor. If you have any questions or concerns, please contact the
researcher or the research advisor. The advisor may ask your name, but all complaints are
kept in confidence.
Participation is voluntary. You may decide not to participate in this study and if you
begin participation you may still decide to stop and withdraw at any time. Your decision
will be respected and will not result in loss of benefits to which you are otherwise
entitled. Having read the above and having had an opportunity to ask any questions,
please sign below if you would like to participate in this research. A copy of this form
will be given to you to retain for future reference. If you have any concerns about your
selection or treatment as a research participant, please contact Sherry May, IRB
Administrator, Office of Sponsored Programs, 25 Kepner Hall, University of Northern
Colorado Greeley, CO 80639; 970-351-1910.
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60

61

APPENDIX G
BANNER HEALTH APPROVAL

62

63

APPENDIX H
STATEMENT OF MUTUAL AGREEMENT
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Baby Boomer HCV Screening Tip Sheet for Billing and Coding
E&M Codes: for well-visits for the baby boomer population (born 1945 to 1965)
include:
• 99386, 99387 new patients for comprehensive preventative visits
• 99396, 99397 established patients for comprehensive preventative visits
• G0438 initial Medicare well-visit
• G0439 subsequent Medicare well-visit
ICD-10 Codes:
If patient has a well-visit that has no abnormal issues addressed (ie Z00.00), the codes
associated with the anti-HCV order are as follows:
1. Z00.00
2. Z11.59 Encounter for screening other viral disease (this code by itself is not
enough, must be secondary to Z00.00)
This is used for the patient who is completely asymptomatic of any symptoms that could
be included in chronic HCV infection differential diagnosis.
If the patient has any symptoms at their well-visit associated with the differential that
could include chronic HCV, or is an established patient that has had vague symptoms that
could be associated with HCV, the coding will be based on the symptoms. Here are
examples of acceptable codes to use for anti-HCV (This list is not comprehensive or
guaranteed, but can be used as examples of codes to apply to the anti-HCV test).
• R53.83 Other fatigue
• M25.50 Pain in unspecified joint (this is related to the symptom of
generalized arthralgia that can be a vague symptom of chronic HCV
infection)
• K76.9 Liver disease, unspecified (or a more specific liver function related
code can be used if patient has had altered LFTs in past)
• K77 Liver disorders in disease classified elsewhere (or a more specific
liver function related code can be used if patient has had altered LFTs in
past)

